The researchers found that overall, the patients who used semaglutide had a 58 percent lower chance of dying from an opioid overdose than their peers who were on other medications, which included older generations of similar drugs like Eli Lillys dulaglutide-based drug Trulicity and even Novos other GLP-1, the liraglutide-based Victoza
As retatrutide remains investigational, its full long-term safety profile has not been established
By Emily Rodriguez, RDN, CSSD|Source reviewed by FormBlends Editorial Standards Team|| Source Reviewed Written by Emily Rodriguez, RDN, CSSD Checked against primary sources by FormBlends Editorial Standards Team In This Article This article is part of our Peptide Therapy collection
Razia Hashmi, the associations vice president of clinical affairs
He spends extra hours each week working to get patients approved for coverage
Book an appointment today for a free weight loss consultation with one of our medical experts